The immunomodulatory role of exosomal microRNA networks in the crosstalk between tumor-associated myeloid-derived suppressor cells and tumor cells.

[1]  L. Cooper,et al.  Topography-mediated immunomodulation in osseointegration; Ally or Enemy. , 2022, Biomaterials.

[2]  P. Krawczyk,et al.  Tumor Microenvironment—A Short Review of Cellular and Interaction Diversity , 2022, Biology.

[3]  Cheng Yang,et al.  Interaction Between microRNAs and Myeloid-Derived Suppressor Cells in Tumor Microenvironment , 2022, Frontiers in Immunology.

[4]  W. Yuan,et al.  Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression , 2022, Frontiers in Immunology.

[5]  Cheng Lu,et al.  The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies , 2022, Frontiers in Immunology.

[6]  Ruiping Zhang,et al.  Exosome-derived microRNA-433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non-small cell lung cancer , 2021, Oncology letters.

[7]  Yangang Xing,et al.  Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression , 2021, Frontiers in Immunology.

[8]  Shuyi Wang,et al.  Tumor-Derived Exosomal MicroRNA-106b-5p Activates the Interaction between EMT-Cancer Cells and M2-Subtype TAMs to Facilitate Colorectal Cancer Metastasis. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  C. Fenselau,et al.  Molecular cargo in myeloid-derived suppressor cells and their exosomes. , 2020, Cellular immunology.

[10]  B. Baradaran,et al.  MicroRNAs and lncRNAs—A New Layer of Myeloid-Derived Suppressor Cells Regulation , 2020, Frontiers in Immunology.

[11]  Jian-hua Zhou,et al.  G-MDSCs-Derived Exosomal miRNA-143-3p Promotes Proliferation via Targeting of ITM2B in Lung Cancer , 2020, OncoTargets and therapy.

[12]  L. Bergamaschi,et al.  microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy , 2020, Frontiers in Immunology.

[13]  Rui Zhang,et al.  Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer , 2020, Oncogene.

[14]  Min Su,et al.  Exosomal miRNAs in tumor microenvironment , 2020, Journal of experimental & clinical cancer research : CR.

[15]  K. Kelnar,et al.  Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours , 2020, British Journal of Cancer.

[16]  D. Gallego-Ortega,et al.  Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer , 2020, Cells.

[17]  N. Dilsiz.  Role of exosomes and exosomal microRNAs in cancer , 2020, Future science OA.

[18]  O. Finn,et al.  Editorial: Myeloid Derived Suppressor Cells as Disease Modulators , 2020, Frontiers in Immunology.

[19]  A. Kotsakis,et al.  Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer , 2019, Cells.

[20]  Zhiyang Li,et al.  Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment , 2019, Journal of Hematology & Oncology.

[21]  Jianping Chen,et al.  The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer , 2019, International journal of molecular sciences.

[22]  Y. Qiu,et al.  MicroRNA networks regulate the differentiation, expansion and suppression function of myeloid-derived suppressor cells in tumor microenvironment , 2019, Journal of Cancer.

[23]  Jianye Xu,et al.  Glioma exosomes mediate the expansion and function of myeloid‐derived suppressor cells through microRNA‐29a/Hbp1 and microRNA‐92a/Prkar1a pathways , 2019, International journal of cancer.

[24]  Peifeng Li,et al.  Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer , 2019, Molecular therapy. Nucleic acids.

[25]  Shichun Tu,et al.  Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer , 2019, Cancer management and research.

[26]  G. Calin,et al.  Role of miRNAs in immune responses and immunotherapy in cancer , 2019, Genes, chromosomes & cancer.

[27]  Hui-qing Jiang,et al.  Cell-free miR-17-5p as a diagnostic biomarker for gastric cancer inhibits dendritic cell maturation , 2019, OncoTargets and therapy.

[28]  W. Fan,et al.  The role and mechanisms of action of microRNAs in cancer drug resistance , 2019, Clinical Epigenetics.

[29]  Shengjun Wang,et al.  MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation , 2019, Front. Immunol..

[30]  Shun Lu,et al.  Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes , 2018, Oncogene.

[31]  E. Safari,et al.  Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives , 2018, Journal of cellular physiology.

[32]  Jinping Sun,et al.  MiR-6991-3p is identified as a novel suppressor in the expansion and activation of myeloid-derived suppressor cells in hepatoma-bearing mice , 2018, OncoTargets and therapy.

[33]  Yuan Qiao,et al.  MicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment , 2018, Front. Immunol..

[34]  L. Mariani,et al.  Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma , 2018, The Journal of clinical investigation.

[35]  Weijian Guo,et al.  MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro , 2018, Cancer medicine.

[36]  Qinglin Liu,et al.  Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways , 2018, Oncogene.

[37]  B. Baradaran,et al.  Myeloid‐derived suppressor cells: Important contributors to tumor progression and metastasis , 2018, Journal of cellular physiology.

[38]  H. Duffau,et al.  Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection , 2018, Cellular and Molecular Neurobiology.

[39]  M. Zöller.  Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease , 2018, Front. Immunol..

[40]  C. Fenselau,et al.  Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment , 2018, The Journal of Immunology.

[41]  T. Tanahashi,et al.  Mechanism of recipient cell-dependent differences in exosome uptake , 2018, BMC Cancer.

[42]  C. Fenselau,et al.  Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions. , 2018, Journal of proteome research.

[43]  T. Whiteside.  The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy. , 2017, Future oncology.

[44]  G. Basso,et al.  PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis , 2017, Oncotarget.

[45]  L. Ding,et al.  MiR‐30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B‐cell lymphoma , 2017, The FEBS journal.

[46]  D. Gabrilovich.  Myeloid-Derived Suppressor Cells , 2017, Cancer Immunology Research.

[47]  J. Utikal,et al.  The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression , 2016, Vaccines.

[48]  Ruo-fan Huang,et al.  MicroRNA expression profiles of granulocytic myeloid-derived suppressor cells from mice bearing Lewis lung carcinoma , 2016, Molecular medicine reports.

[49]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[50]  Y. Teng,et al.  Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis , 2016, Oncogene.

[51]  Ri-sheng Que,et al.  Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer , 2016, Journal of Zhejiang University-SCIENCE B.

[52]  Xuetao Cao,et al.  Immunosuppressive cells in tumor immune escape and metastasis , 2016, Journal of Molecular Medicine.

[53]  J. Redzic,et al.  Glioma-derived extracellular vesicles selectively suppress immune responses. , 2016, Neuro-oncology.

[54]  T. Whiteside.  Exosomes and tumor-mediated immune suppression. , 2016, The Journal of clinical investigation.

[55]  Zhongyu Liu,et al.  MiR-690, a Runx2-targeted miRNA, regulates osteogenic differentiation of C2C12 myogenic progenitor cells by targeting NF-kappaB p65 , 2016, Cell & Bioscience.

[56]  Anfei Huang,et al.  miR‐34a inhibits the apoptosis of MDSCs by suppressing the expression of N‐myc , 2016, Immunology and cell biology.

[57]  M. Yousefi,et al.  The immunobiology of myeloid-derived suppressor cells in cancer , 2016, Tumor Biology.

[58]  K. Vanderkerken,et al.  The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells , 2015, Oncotarget.

[59]  F. Martelli,et al.  Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210. , 2015, Cancer research.

[60]  Yuan Zhang,et al.  MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression , 2015, PloS one.

[61]  Yue Zhang,et al.  MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1 , 2015, The Journal of Immunology.

[62]  A. Alimonti,et al.  Molecular Pathways: Targeting Tumor-Infiltrating Myeloid-Derived Suppressor Cells for Cancer Therapy , 2015, Clinical Cancer Research.

[63]  P. Altevogt,et al.  Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment , 2015, Oncoimmunology.

[64]  Joana A. Vidigal,et al.  The biological functions of miRNAs: lessons from in vivo studies. , 2015, Trends in cell biology.

[65]  T. Kuzel,et al.  Regulating Tumor Myeloid-Derived Suppressor Cells by MicroRNAs. , 2015, Cancer cell & microenvironment.

[66]  Meghan C. Burke,et al.  Ubiquitinated Proteins in Exosomes Secreted by Myeloid-Derived Suppressor Cells , 2014, Journal of proteome research.

[67]  F. Sánchez‐Madrid,et al.  Sorting it out: regulation of exosome loading. , 2014, Seminars in cancer biology.

[68]  S. Xiong,et al.  miR-34a expands myeloid-derived suppressor cells via apoptosis inhibition. , 2014, Experimental cell research.

[69]  Jingyan Xie,et al.  Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression , 2014, Cellular and Molecular Immunology.

[70]  Meghan C. Burke,et al.  Exosomes from myeloid-derived suppressor cells carry biologically active proteins. , 2014, Journal of proteome research.

[71]  Jing Zhang,et al.  MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells , 2014, The Journal of Immunology.

[72]  M. Nagarkatti,et al.  Distinct MicroRNA Expression Profile and Targeted Biological Pathways in Functional Myeloid-derived Suppressor Cells Induced by Δ9-Tetrahydrocannabinol in Vivo , 2013, The Journal of Biological Chemistry.

[73]  Kathleen R. Cho,et al.  Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. , 2013, Immunity.

[74]  B. Ammori,et al.  Myeloid‐derived suppressor cells in cancer: recent progress and prospects , 2013, Immunology and cell biology.

[75]  F. Agani,et al.  Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR‐199a/125b and DNA methylation , 2012, EMBO reports.

[76]  Xuetao Cao,et al.  MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN , 2012, The Journal of Immunology.

[77]  A. Pasquinelli.  MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship , 2012, Nature Reviews Genetics.

[78]  Yuan Zhang,et al.  miR‐223 suppresses differentiation of tumor‐induced CD11b+Gr1+myeloid‐derived suppressor cells from bone marrow cells , 2011, International journal of cancer.

[79]  Yuan Zhang,et al.  Both miR-17-5p and miR-20a Alleviate Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating STAT3 Expression , 2011, The Journal of Immunology.

[80]  Mirko H. H. Schmidt,et al.  miR-126 and miR-126*: New Players in Cancer , 2010, TheScientificWorldJournal.

[81]  Ryan M. O’Connell,et al.  Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.

[82]  B. Chauffert,et al.  Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.

[83]  A. Mantovani,et al.  Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals , 2009, Proceedings of the National Academy of Sciences.

[84]  Ryan M. O’Connell,et al.  MicroRNAs: new regulators of immune cell development and function , 2008, Nature Immunology.

[85]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[86]  H. Lodish,et al.  Micromanagement of the immune system by microRNAs , 2008, Nature Reviews Immunology.

[87]  C. L. Ventola.  Cancer Immunotherapy, Part 3: Challenges and Future Trends. , 2017, P & T : a peer-reviewed journal for formulary management.

[88]  Derek H. Oakley,et al.  Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. , 2016, Neuro-oncology.

[89]  M. El Gazzar,et al.  microRNAs as potential regulators of myeloid-derived suppressor cell expansion , 2014, Innate immunity.